Resource Library
Whitepapers
Tackling false-positive endotoxin results: A practical approach to β-glucans and LAL reagent variability
β-glucan process-related impurities introduced into pharmaceutical products during manufacturing can cause false-positive results on endotoxin tests. In this whitepaper, we identify new approaches to tackle the potential issues, including the removal of β-glucan and improving the endotoxin test qualification process.
β-glucan process-related impurities introduced into pharmaceutical products during manufacturing can cause false-positive results on endotoxin tests. In this whitepaper, we identify new approaches to tackle the potential issues, including the removal of β-glucan and improving the endotoxin test qualification process.